Evaluation of DLA promoters in Doberman hepatitis

about

Evaluation of DLA promoters in Doberman hepatitis

Item

http://www.wikidata.org/entity/Q58859993

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

2011年學術文章

@zh-hant

name

Evaluation of DLA promoters in Doberman hepatitis

@en

Evaluation of DLA promoters in Doberman hepatitis

@nl

type

Item

label

Evaluation of DLA promoters in Doberman hepatitis

@en

Evaluation of DLA promoters in Doberman hepatitis

@nl

prefLabel

Evaluation of DLA promoters in Doberman hepatitis

@en

Evaluation of DLA promoters in Doberman hepatitis

@nl

P1476

Evaluation of DLA promoters in Doberman hepatitis

@en

P2093

H Dyggve

http://www.w3.org/2001/XMLSchema#string

M Speeti

http://www.w3.org/2001/XMLSchema#string

T Spillmann

http://www.w3.org/2001/XMLSchema#string

P2860

Genetic control of MHC class II expression

Mini-review: Specificity and expression of CIITA, the master regulator of MHC class II genes

MHC2TA is associated with differential MHC molecule expression and susceptibility to rheumatoid arthritis, multiple sclerosis and myocardial infarction

B-cell-specific and interferon-gamma-inducible regulation of the HLA-DR alpha gene

CIITA variation in the presence of HLA-DRB1*1501 increases risk for multiple sclerosis.

Expression of MHC class II molecules in different cellular and functional compartments is controlled by differential usage of multiple promoters of the transactivator CIITA.

Two distinct gamma interferon-inducible promoters of the major histocompatibility complex class II transactivator gene are differentially regulated by STAT1, interferon regulatory factor 1, and transforming growth factor beta

How selection shapes variation of the human major histocompatibility complex: a review.

Regulation of major histocompatibility complex class II gene expression, genetic variation and disease.

Endothelial expression of MHC class II molecules in autoimmune disease.

P304

446-450

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1399-0039.2011.01784.X

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Hannes Lohi

Lorna J. Kennedy

Seppo Meri

P577

2011-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22077625

http://www.w3.org/2001/XMLSchema#string